CJC-1295 & GHRP-2 Blend
A potent research blend pairing CJC-1295 (Mod GRF 1-29) with GHRP-2 for strong synergistic GH release with good GH-axis selectivity.
⚠ Research & Educational Use Only. CJC-1295 & GHRP-2 Blend is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.
- Strong GH pulse amplitude (3-5x each peptide alone)
- Good GH selectivity (less cortisol elevation than GHRP-6)
- Potent IGF-1 elevation for body composition research
- CJC-1295 & GHRP-2 Blend is not FDA-approved for human use. It is a research chemical for scientific study only.
Research At a Glance
- Strong GH pulse amplitude (3-5x each peptide alone)
- Good GH selectivity (less cortisol elevation than GHRP-6)
- Potent IGF-1 elevation for body composition research
- Well-characterized in human pharmacokinetic studies
What is CJC-1295 & GHRP-2 Blend?
CJC-1295 & GHRP-2 Blend combines CJC-1295 (no DAC / Mod GRF 1-29) with GHRP-2, a potent GHS-R1a agonist with excellent GH-stimulating efficacy. GHRP-2 produces stronger GH pulses than ipamorelin at equivalent doses but with modestly higher cortisol and prolactin elevation.
What It Is
- CJC-1295 (no DAC): GHRH analogue for GHRHR stimulation
- GHRP-2: potent GHS-R1a agonist; high GH output with moderate cortisol/prolactin side effect profile
- Selected when maximum GH amplitude is the research goal and clean selectivity (ipamorelin) is secondary
How It Works
- Standard GHRH + GHRP dual-receptor mechanism
- GHRP-2's higher GHS-R1a binding affinity vs ipamorelin produces somewhat larger GH peaks
- Combined GH amplitude: 3-5x either peptide alone
Key Research Findings
- GH peaks of 40-60 ng/mL in responsive individuals at standard doses
- IGF-1 elevation: 60-80% above baseline at 3 months
- Cortisol: transient 20-25% elevation above baseline at peak GHRP-2 concentration; normalizes within 3 hours
Dosing From the Literature
- CJC-1295 (no DAC) 100-200 mcg + GHRP-2 100-200 mcg per injection
- Twice daily; keep GHRP-2 below 250 mcg per injection
Storage and Handling
- Lyophilised: 2-8 degrees C; 24 months
- Reconstituted: 2-8 degrees C; use within 30 days
Key Research Benefits
Documented effects observed in preclinical and clinical studies on CJC-1295 & GHRP-2 Blend. See all Peptide Blends peptides for comparison.
Side Effects & Risks
Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports.
Dosing Data from the Literature
Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.
Administration in Research Settings
Standard reconstitution and administration methodology for laboratory research use.
Subcutaneous injection on empty stomach.
Explore Further
Quick Reference
More in Peptide Blends
- Sermorelin & Ipamorelin Blend
- Sermorelin & GHRP-2 Blend
- Sermorelin & GHRP-6 Blend
- Sermorelin & GHRP-6 & GHRP-2 Triple Blend
Research Use Only
This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.